Online Program

Starting the conversation: How to tell your friends about hemophilia

Monday, November 4, 2013 : 12:55 p.m. - 1:00 p.m.

Gretchen Simmons, MPH, MCHES, | Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA
Hemophilia affects an estimated 20,000 people in the United States. Hemophilia may result in severe complications, some of which are painful and potentially fatal. The Division of Blood Disorders (DBD), located within the National Center on Birth Defects and Developmental Disabilities, is committed to raising awareness about hemophilia and reducing the morbidity and mortality associated with this disorder. In conjunction with ICF International, DBD created this video, which features a child affected by hemophilia. The video provides insight into how one can talk to friends about hemophilia. By raising awareness about hemophilia and promoting education on the management of this disorder, this video contributes to improved health outcomes for people affected by hemophilia.

Learning Areas:

Public health or related education

Learning Objectives:
List at least one common misperception the video dispels about people with hemophilia.

Keyword(s): Special Populations, Public Health Agency Roles

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I was the technical monitor on a contract awarded to ICF International to conduct formative research to inform the development of the video and to test the messages in the video. As a Project Officer on two large cooperative agreements aimed at developing health promotion programs for people with hemophilia, I have been involved in development of communication products and messages to raise awareness of hemophilia and educate people about the management of this disorder.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.